MedPath

A clinical study of non-invasive diagnostic criteria for detrusor underactivity

Active, not recruiting
Conditions
UAB syndrome
Registration Number
jRCT1070230013
Lead Sponsor
TAIHO PHARMACEUTICAL CO., LTD.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Recruiting
Sex
All
Target Recruitment
186
Inclusion Criteria

-Written consent was given for participation in the study.

  • Age at the time of informed consent is 18 years or older.
  • Willingness to adhere to the visit schedule and procedures specified in this study, and compliance is possible -Of the three voiding symptoms of UAB's syndrome as defined by ICS (hypovolemia, delayed voiding, abdominal pressure voiding), having any two or more symptoms for at least 12 weeks
Exclusion Criteria

-Researchers and others judged the participation of this study to be inappropriate.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
-

Diagnostic predictive value based on noninvasive diagnostic criteria for DU.(%)

Secondary Outcome Measures
NameTimeMethod
BCI (men) and PIP1 (women) tabulation

Summarized statistics of BCI (men) and PIP1 (women).

Urinary micro RNA analysis

Only in collaborating laboratories where micro RNA analysis is feasible

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.